Petauri Acquires Formulary Insights
November 13, 2024
Petauri, a PE‑backed pharmaceutical services platform based in Nashville, has acquired Formulary Insights and merged the business into Petauri Advisors to expand its market access research and strategy capabilities. The acquisition broadens Petauri’s payer and market access offerings for biopharmaceutical clients and is supported by Oak Hill Capital, which is backing the platform with a multi‑hundred million dollar commitment.
- Buyers
- Petauri
- Targets
- Formulary Insights
- Platforms
- Petauri
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Petauri Acquires Artia Solutions to Expand Medicaid Market Access Capabilities
July 15, 2025
Healthcare Services
Petauri, a purpose-built pharmaceutical services platform backed by Oak Hill Capital, has acquired Artia Solutions, a Medicaid market access consultancy founded in 2005. The deal adds deep state Medicaid policy and reimbursement expertise to Petauri's platform, strengthening its public payer capabilities and end-to-end market access offerings for biopharma clients.
-
Petauri Acquires FORCE Communications
February 14, 2024
Healthcare Services
Petauri, a pharmaceutical services platform backed by Oak Hill Capital, has acquired FORCE Communications and its three independent agencies — DRIVE, MOMENTUM, and PROPEL. The add-on expands Petauri's scientific communications and medical education capabilities as the platform continues to build scale in medical affairs, market access, patient services, and data and analytics.
-
Petauri Health (Oak Hill) Acquires The Kinetix Group
June 13, 2023
Healthcare Services
Petauri Health, a pharmaceutical commercialization platform formed by Oak Hill Capital, has acquired The Kinetix Group (TKG), a New York–based market access, access marketing, and medical affairs agency. The Kinetix founders will remain in leadership roles as TKG becomes the inaugural add-on to the Petauri platform, expanding the platform's market access, medical affairs, and real-world evidence capabilities.
-
Petauri Acquires Bluprint Oncology, Cogency, Verascity and Blendworks from Brightly Network
August 14, 2024
Healthcare Services
Petauri, the Oak Hill Capital–backed pharmaceutical services platform, acquired four U.S.-based medical communications agencies — Bluprint Oncology, Cogency, Verascity, and Blendworks — from the Brightly Network. The additions expand Petauri Advance's oncology, hematology and rare-disease communications capabilities and increase the platform's depth in medical and commercial strategy, engagement, and education.
-
Olympus Partners Acquires PAI Pharma
February 24, 2025
Pharmaceuticals
Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.
-
VettaFi Acquires Advisor Perspectives
October 20, 2022
Financial Services
VettaFi has acquired Advisor Perspectives, the leading digital publisher and newsletter platform serving registered investment advisors, wealth managers, and financial planners. The acquisition expands VettaFi’s content, advisor database and distribution capabilities as part of its strategy to grow its data, analytics and digital distribution footprint in the financial-advisor market.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.